Eduardo Dei‐Cas
About
In The Last Decade
Eduardo Dei‐Cas
210 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 124
- Infectious Diseases 3.0k
- Epidemiology 2.9k
- Parasitology 1.8k
- Molecular Biology 544
- Surgery 372
Countries citing papers authored by Eduardo Dei‐Cas
This map shows the geographic impact of Eduardo Dei‐Cas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Dei‐Cas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Dei‐Cas more than expected).
Fields of papers citing papers by Eduardo Dei‐Cas
This network shows the impact of papers produced by Eduardo Dei‐Cas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Dei‐Cas. The network helps show where Eduardo Dei‐Cas may publish in the future.
Co-authorship network of co-authors of Eduardo Dei‐Cas
This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Dei‐Cas. A scholar is included among the top collaborators of Eduardo Dei‐Cas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Dei‐Cas. Eduardo Dei‐Cas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Genetic characterization of Pneumocystis jirovecii in patients dying of AIDS, IPK, 1995-2008 | 1 |
| 3 | 45 | |
| 4 | 13 | |
| 5 | SSU- rRNA Gene Analysis of Cryptosporidium spp. in HIV Positive and Negative Patients | 13 |
| 6 | 39 | |
| 7 | Involvement of [beta]-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin. | 44 |
| 8 | Nécessité d'un suivi sérologique post-partum de la toxoplasmose congénitale chez les femmes séronégatives en fin de grossesse. | 2 |
| 9 | 11 | |
| 10 | 4 | |
| 11 | 22 | |
| 12 | 45 | |
| 13 | 11 | |
| 14 | 55 | |
| 15 | 35 | |
| 16 | 10 | |
| 17 | Intranasal Inoculation of Mouse, Rat or Rabbit-Derived Pneumocystis to SCID Mice | 38 |
| 18 | Production of a monoclonal antibody using lymphocytes from Pneumocystis infected mice. | 1 |
| 19 | Place actuelle de l'amphotéricine B dans le traitement des mycoses profondes. | 1 |
| 20 | Plasmodium falciparum in vitro: development and volume variations in hypo- and hyper-osmolar media. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.